VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 124 filers reported holding VBI VACCINES INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,700 | -22.5% | 35,315 | 0.0% | 0.00% | – |
| Q4 2022 | $13,812 | -44.6% | 35,315 | 0.0% | 0.00% | – |
| Q3 2022 | $24,925 | -80.8% | 35,315 | -54.8% | 0.00% | – |
| Q1 2022 | $129,654 | -44.6% | 78,105 | -21.9% | 0.00% | – |
| Q4 2021 | $234,000 | -18.2% | 99,943 | +1.5% | 0.00% | – |
| Q3 2021 | $286,000 | -18.5% | 98,513 | -5.9% | 0.00% | – |
| Q2 2021 | $351,000 | +12.5% | 104,671 | +4.5% | 0.00% | – |
| Q1 2021 | $312,000 | +6.8% | 100,188 | -5.6% | 0.00% | – |
| Q4 2020 | $292,000 | +5.0% | 106,160 | +9.0% | 0.00% | – |
| Q3 2020 | $278,000 | -11.5% | 97,364 | -2.8% | 0.00% | – |
| Q2 2020 | $314,000 | +234.0% | 100,200 | +0.9% | 0.00% | – |
| Q1 2020 | $94,000 | +42.4% | 99,281 | +420.4% | 0.00% | – |
| Q1 2018 | $66,000 | -47.6% | 19,079 | -35.3% | 0.00% | – |
| Q4 2017 | $126,000 | – | 29,509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |